Stryker Corporation (SYK) Income Statement
SYK 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSYK revenue and net income
Where SYK's revenue goes
2025Each bar shows an amount and its share of revenue. SYK kept 12.9% of revenue as net income.
SYK profit margins
SYK growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +11.2% | +10.8% | +11.8% | +9.7% |
| Gross profit | +10.5% | +13.3% | +12.9% | +9.7% |
| Operating income | +32.5% | +9.4% | +10.1% | +8.1% |
| Net income | +8.5% | +11.2% | +15.2% | +8.5% |
| EPS (diluted) | +11.8% | +13.4% | +12.9% | +10.3% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SYK quarterly EPS vs estimates
Stryker beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: October 29, 2026 (estimate $3.59).
SYK income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.12B | $22.59B | $20.50B | $18.45B | $17.11B | $14.35B | $14.88B | $13.60B | $12.44B | $11.32B |
| Cost of revenue | $9.05B | $8.05B | $8.00B | $7.41B | $6.40B | $5.60B | $5.50B | $5.00B | $4.54B | $4.08B |
| Gross profit | $16.07B | $14.54B | $12.49B | $11.04B | $10.71B | $8.75B | $9.38B | $8.60B | $7.90B | $7.25B |
| Research & development | $1.58B | $1.47B | $1.29B | $1.23B | $1.13B | $905.0M | $971.0M | $862.0M | $787.0M | $715.0M |
| Sales, general & admin | $8.22B | $7.68B | $7.13B | $6.04B | $5.75B | $5.36B | $5.36B | $5.10B | $4.55B | $4.14B |
| Total operating expenses | $11.18B | $10.86B | $8.21B | $7.31B | $6.95B | $5.72B | $5.99B | $5.50B | $5.14B | $4.67B |
| Operating income | $4.89B | $3.69B | $4.28B | $3.73B | $3.76B | $3.03B | $3.39B | $3.10B | $2.77B | $2.58B |
| Interest income | $486.0M | $257.0M | $281.0M | $243.0M | $269.0M | $213.0M | $125.0M | $139.0M | $178.0M | $180.0M |
| Interest expense | $607.0M | $396.0M | $356.0M | $337.0M | $337.0M | $315.0M | $287.0M | $264.0M | $247.0M | $228.0M |
| Income before taxes | $4.51B | $3.49B | $3.67B | $2.68B | $2.28B | $1.95B | $2.56B | $2.36B | $2.06B | $1.92B |
| Income taxes | $1.27B | $499.0M | $508.0M | $325.0M | $287.0M | $355.0M | $479.0M | −$1.20B | $1.04B | $274.0M |
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | $1.99B | $1.60B | $2.08B | $3.55B | $1.02B | $1.65B |
| EBITDA | $6.31B | $6.01B | $5.06B | $4.02B | $3.61B | $3.08B | $3.63B | $3.34B | $2.95B | $2.69B |
| EPS (diluted) | $13.63 | $12.19 | $10.60 | $9.34 | $9.09 | $7.43 | $8.26 | $7.31 | $6.49 | $5.80 |
| Gross margin | 64.0% | 64.4% | 61.0% | 59.8% | 62.6% | 61.0% | 63.0% | 63.2% | 63.5% | 64.0% |
| Operating margin | 19.5% | 16.3% | 20.9% | 20.2% | 22.0% | 21.1% | 22.8% | 22.8% | 22.2% | 22.8% |
| Net margin | 12.9% | 13.2% | 15.4% | 12.8% | 11.7% | 11.1% | 14.0% | 26.1% | 8.2% | 14.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.59B | $6.02B | $7.17B | $6.06B | $6.02B | $5.87B | $6.44B | $5.49B | $5.42B | $5.24B | $5.82B | $4.91B |
| Cost of revenue | $2.09B | $2.21B | $2.49B | $2.21B | $2.11B | $2.19B | $2.45B | $2.10B | $2.10B | $2.05B | $2.26B | $1.89B |
| Gross profit | $4.50B | $3.81B | $4.68B | $3.85B | $3.91B | $3.68B | $3.99B | $3.39B | $3.32B | $3.19B | $3.55B | $3.02B |
| Research & development | $434.0M | $413.0M | $401.0M | $410.0M | $407.0M | $393.0M | $342.0M | $364.0M | $352.0M | $356.0M | $328.0M | $335.0M |
| Sales, general & admin | $2.23B | $2.28B | $2.13B | $2.04B | $1.99B | $2.30B | $2.10B | $1.90B | $1.85B | $1.84B | $1.94B | $1.70B |
| Total operating expenses | $2.84B | $2.87B | $2.72B | $2.72B | $2.80B | $2.50B | $2.33B | $2.19B | $2.17B | $2.19B | $2.13B | $2.03B |
| Operating income | $1.66B | $936.0M | $1.96B | $1.14B | $1.11B | $1.18B | $1.66B | $1.21B | $1.16B | $1.00B | $1.43B | $991.0M |
| Interest income | — | — | $576.0M | $28.0M | $24.0M | $38.0M | $47.0M | $30.0M | — | — | — | $15.0M |
| Interest expense | $141.0M | $148.0M | $381.0M | $157.0M | $159.0M | $137.0M | — | — | — | — | — | — |
| Income before taxes | $1.56B | $850.0M | $1.71B | $1.03B | $1.02B | $764.0M | $528.0M | $1.04B | $998.0M | $923.0M | $1.23B | $869.0M |
| Income taxes | $288.0M | $105.0M | $856.0M | $170.0M | $132.0M | $110.0M | −$18.0M | $209.0M | $173.0M | $135.0M | $83.0M | $177.0M |
| Net income | $1.28B | $745.0M | $849.0M | $859.0M | $884.0M | $654.0M | $546.0M | $834.0M | $825.0M | $788.0M | $1.14B | $692.0M |
| EBITDA | $2.00B | $1.30B | $2.03B | $1.36B | $1.62B | $1.04B | $792.0M | $1.31B | $1.26B | $1.18B | $1.48B | $1.13B |
| EPS (diluted) | $3.69 | $2.60 | $4.47 | $3.19 | $3.13 | $2.84 | $4.01 | $2.87 | $2.81 | $2.50 | $3.46 | $2.46 |
| Gross margin | 68.3% | 63.3% | 65.2% | 63.6% | 65.0% | 62.7% | 62.0% | 61.8% | 61.3% | 60.9% | 61.1% | 61.5% |
| Operating margin | 25.2% | 15.5% | 27.3% | 18.7% | 18.5% | 20.1% | 25.8% | 22.0% | 21.4% | 19.1% | 24.5% | 20.2% |
| Net margin | 19.4% | 12.4% | 11.8% | 14.2% | 14.7% | 11.1% | 8.5% | 15.2% | 15.2% | 15.0% | 19.7% | 14.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SYK's financial statements (latest annual report filed February 11, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SYK financial results
In fiscal year 2025 (ended December 31, 2025), Stryker reported revenue of $25.1 billion, up 11.2% from the year before. It had net income of $3.2 billion (up 8.5%), a net profit margin of 12.9%. Diluted earnings per share came to $13.63. Over five years revenue grew at an average rate of 11.8% a year.
See the SYK stock overview for the latest quote and news, or the SYK chart for price history and technical indicators.
SYK income statement FAQ
What is Stryker's annual revenue?
Stryker reported total revenue of $25.1 billion for fiscal year 2025, which ended on December 31, 2025. That was up 11.2% from $22.6 billion the previous year.
Is Stryker profitable?
Yes. Stryker reported net income of $3.2 billion in fiscal 2025, a net profit margin of 12.9%; its operating margin was 19.5%.
What is Stryker's gross margin?
Stryker's gross margin was 64.0% in fiscal 2025: for every $100 of revenue, Stryker kept $64 after the direct cost of its products and services.
How much does Stryker spend on research and development?
Stryker spent $1.6 billion on research and development in fiscal 2025, 6.3% of revenue.
How fast is Stryker growing?
Revenue grew 11.8% a year on average over the last five fiscal years, from $14.4 billion to $25.1 billion.
What are Stryker's earnings per share?
Stryker earned $13.63 per diluted share in fiscal 2025, compared with $12.19 a year earlier.
When will Stryker report its next earnings?
Stryker is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 after the market closes.
When does Stryker's fiscal year end?
Stryker's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 11, 2026.